Abstract
Vasculogenic mimicry (VM) has been generally recognized as a new pattern of tumor neovascularization. It presents in many human malignancies. Till now, there is no report about VM in gastric adenocarcinoma (GAC). In this study, we collected 173 paraffin-embedded human GAC samples, with detailed follow-up and clinicopathologic data. CD31/ periodic acid-Schiff (PAS) double staining, immunohistochemical staining of CK8 & 18 and laminin were performed to validate the existence of VM in GAC. Microvascular density (MVD) and vasulogenic mimicry density (VMD) were counted respectively. VM was observed in 40 of the 173 GAC patients, especially in poorly differentiated GAC (P = 0.014). Patients with VM were prone to hematogenous metastasis and distant recurrence compared with patients without VM (P = 0.020, 0.029). Higher VMD values was also associated with hematogenous metastasis (P = 0.003). Immunohistochemical staining index (SI) of hypoxia-inducible factor 1α (HIF-1α), vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2, and MMP-9 were compared between the VM and non-VM group. The SI of four factors were all higher in the VM group than those of non-VM group (P = 0.000, 0.000, 0.004, 0.009, respectively). The Kaplan-Meier survival analysis showed that the VM group has shorter life span compared with non-VM group (P = 0.022). Cox proportional hazards model indicated that the presence of VM and TNM stage were independent predictors of poor prognosis (P = 0.039 and 0.004) for GAC. In conclusion, VM exists in GAC, especially in poorly differentiated GAC. Additionally, it is an unfavorable prognostic indictor for GAC. Hypoxia may play a role in VM formation in GAC.
Similar content being viewed by others
Abbreviations
- ECM:
-
extracellular matrix
- EDV:
-
endothelium dependent vessel
- GAC:
-
gastric adenocarcinoma
- HIF-1α:
-
hypoxia-inducible factor 1 α
- MMP:
-
matrix metalloproteinase
- MV:
-
mosaic vessel
- MVD:
-
microvascular density
- PAS:
-
periodic acid-Schiff
- SI:
-
staining index
- RBCs:
-
red blood cells
- VEGF:
-
vascular endothelial growth factor
- VM:
-
vasculogenic mimicry
- VMD:
-
vasulogenic mimicry density
References
Maniotis AJ, Folberg R, Hess A et al (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739–752
Chang YS, di Tomaso E, McDonald DM et al (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97:14608–14613
Chen X, Maniotis AJ, Majumdar D et al (2002) Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci 43:2533–2539
Folberg R, Mehaffey M, Gardner LM et al (1997) The microcirculation of choroidal and ciliary body melanomas. Eye 11:227–238
Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156:361–381
Sood AK, Seftor EA, Fletcher MS et al (2001) Molecular determinants of ovarian cancer plasticity. Am J Pathol 158:1279–1288
Liu C, Huang H, Doñate F et al (2002) Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res 62:5470–5475
Shirakawa K, Tsuda H, Heike Y et al (2001) Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res 61:445–451
Sun B, Zhang S, Zhang D et al (2006) Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep 16:693–698
Sun B, Zhang S, Zhao X et al (2004) Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 25:1609–1614
van der Schaft DW, Hillen F, Pauwels P et al (2005) Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res 65:11520–11528
Sun B, Qie S, Zhang S et al (2008) Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol 39:846–856
Folberg R, Maniotis AJ (2004) Vasculogenic mimicry. APMIS 112:508–525
Shirakawa K, Wakasugi H, Heike Y et al (2002) Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 99:821–828
Pisani P, Parkin DM, Bray F et al (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18–29
Tanigawa N, Amaya H, Matsumura M et al (1996) Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 56:2671–2676
Zhao HC, Qin R, Chen XX et al (2006) Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol 12:7598–7603
Hasan J, Byers R, Jayson GC (2002) Intra-tumoural microvessel density in human solid tumours. Br J Cancer 86:1566–1577
Issam Beyrouti M, Beyrouti R, Ben Amar M et al (2007) Linitis plastica. Presse Med 36:1782–1786
Sood AK, Fletcher MS, Coffin JE et al (2004) Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol 190:899–909
Hendrix MJ, Seftor EA, Kirschmann DA et al (2003) Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci 995:151–161
Hess AR, Seftor EA, Seftor RE et al (2003) Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 63:4757–4762
Seftor RE, Seftor EA, Koshikawa N et al (2001) Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix / metallo-proteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 61:6322–6327
Sun B, Zhang D, Zhang S et al (2007) Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett 249:188–197
Seftor EA, Meltzer PS, Kirschmann DA et al (2002) Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 19:233–246
Höckel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93:266–276
Liao D, Johnson RS (2007) Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26:281–290
Cabuk D, Basaran G, Celikel C et al (2007) Vascular endothelial growth factor, hypoxia-inducible factor 1a and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival. Oncology 72:111–117
Mizokami K, Kakeji Y, Oda S et al (2006) Clinicopathologic significance of hypoxia-inducible factor 1a overexpression in gastric carcinomas. J Surg Oncol 94:149–154
Griffiths EA, Pritchard SA, Welch IM et al (2005) Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer 41:2792–2805
Zhang J, Gao Q (2008) Morphology and mechanism research of gastric cancer vasculogenic mimicry. Journal of Chongqing Medical University 33:1063–1066
Park SH, Han JK, Kim TK et al (1999) Unusual gastric tumors: radiologic-pathologic correlation. Radiographics 19:1435–1446
Kunisaki C, Akiyama H, Nomura M et al (2006) Clinicopathologic properties of poorly-differentiated adenocarcinoma of the stomach: comparison of solid- and non-solid-types. Anticancer Res 26:639–646
Adachi Y, Yasuda K, Inomata M et al (2000) Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 89:1418–1424
Strosberg JR, Nasir A, Hodul P et al (2008) Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res 2:113–125
Sood AK, Fletcher MS, Hendrix MJ (2002) The embryonic-like properties of aggressive human tumor cells. J Soc Gynecol Investig 9:2–9
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Kim SJ, Rabbani ZN, Dewhirst MW et al (2005) Expression of HIF-1α CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 49:325–335
Malemud CJ (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11:1696–1701
Acknowledgements
This work was supported by a grant from a Key project of the National Natural Science Foundation of China (No.30830049), the National Natural Science Foundation of China (No.30770828), and Tianjin Natural Science Foundation (Nos.09ZCZDSF04400).
Author information
Authors and Affiliations
Corresponding author
Additional information
Man Li and Baocun Sun contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, M., Gu, Y., Zhang, Z. et al. Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma. Pathol. Oncol. Res. 16, 259–266 (2010). https://doi.org/10.1007/s12253-009-9220-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-009-9220-7